ATNFW
Income statement / Annual
Last year (2024), 180 Life Sciences Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, 180 Life Sciences Corp.'s net income was -$6.17 M.
See 180 Life Sciences Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$58.28 K
|
$105.68 K
|
$109.00 K
|
$116.30 K
|
$125.33 K
|
$72.24 K
|
$0.00
|
$0.00
|
| Gross Profit |
-$58.28 K
|
-$106.00 K
|
-$109.00 K
|
-$116.00 K
|
-$125.00 K
|
-$72.24 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.40 M
|
$2.79 M
|
$2.43 M
|
$3.95 M
|
$2.29 M
|
$2.04 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$4.36 M
|
$10.65 T
|
$15.47 M
|
$11.69 M
|
$3.36 M
|
$18.85 M
|
$599.08 K
|
$343.88 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.36 M
|
$10.59 M
|
$15.47 M
|
$11.58 M
|
$3.23 M
|
$18.85 M
|
$599.08 K
|
$343.88 K
|
| Other Expenses |
$510.45 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$6.27 M
|
$13.37 M
|
$17.90 M
|
$15.64 M
|
$5.52 M
|
$20.89 M
|
$599.08 K
|
$343.88 K
|
| Cost And Expenses |
$6.32 M
|
$13.48 M
|
$17.90 M
|
$15.64 M
|
$5.65 M
|
$20.89 M
|
$599.08 K
|
$343.88 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.73 K
|
$2.05 M
|
$663.02 K
|
| Interest Expense |
$50.64 K
|
-$44.83 B
|
$26.67 K
|
$186.21 K
|
$1.09 M
|
$185.14 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$58.28 K
|
$105.68 K
|
$109.00 K
|
$116.30 K
|
$125.33 K
|
$72.24 K
|
$0.00
|
$0.00
|
| EBITDA |
-$6.33 M |
-$22.13 M |
-$39.53 M |
-$20.05 M |
-$9.69 M |
-$25.15 M |
-$599.00 K |
-$344.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$139.00 K
|
-$8.81 M
|
-$21.77 M
|
-$4.71 M
|
-$5.26 M
|
-$4.54 M
|
$2.05 M
|
$663.02 K
|
| Income Before Tax |
-$6.46 M
|
-$22.29 M
|
-$39.67 M
|
-$20.35 M
|
-$10.90 M
|
-$25.40 M
|
$1.45 M
|
$319.13 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$296.00 K
|
-$2.35 M
|
-$943.00 K
|
-$23.20 K
|
-$20.43 K
|
-$9.50 K
|
$413.00 K
|
$195.37 K
|
| Net Income |
-$6.17 M
|
-$19.94 M
|
-$38.73 T
|
-$20.32 T
|
-$12.01 T
|
-$25.39 M
|
$1.04 M
|
$123.76 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-6.74 |
-52.59 |
-1966837.38 |
-2463175.7 |
-251329412.01 |
-874.45 |
0.25 |
0.0359 |
| EPS Diluted |
-6.74 |
-52.59 |
-1966837.38 |
-2463175.7 |
-251329412.01 |
-874.45 |
0.0699 |
0.0131 |
| Weighted Average Shares Out |
$915.37 K
|
$379.09 K
|
$19.69 M
|
$8.25 M
|
$47.77 K
|
$4.22 M
|
$4.14 M
|
$3.45 M
|
| Weighted Average Shares Out Diluted |
$915.37 K
|
$379.09 K
|
$19.69 M
|
$8.25 M
|
$47.77 K
|
$4.22 M
|
$14.88 M
|
$9.44 M
|
| Link |
|
|
|
|
|
|
|
|
